Chargement en cours...
Assessing Pharmacokinetic Marker Correlates of Outcome, with Application to Antibody Prevention Efficacy Trials
The Antibody Mediated Prevention (AMP) efficacy trials are the first studies to evaluate whether passive administration of a broadly neutralizing monoclonal antibody (mAb) can prevent HIV acquisition. The trials randomize 4600 HIV-negative volunteers to receive 10 infusions of the mAb VRC01 or place...
Enregistré dans:
| Publié dans: | Stat Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736712/ https://ncbi.nlm.nih.gov/pubmed/31313349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.8310 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|